KOSSEL MEDTECH, THE GUARDIAN OF HEALTH

The core R&D team was co-founded by senior technical personnel studying in the United States for decades and a domestic R&D and operation team...
 

COMPANY SCALE

 
Kossel Medtech (Suzhou) Co., Ltd.The total facility is more than 5,000 square meters. We have around 200 employees and 40% of them with bachelor degrees.
 

PRODUCT QUALITY

 
Kossel was certified as National High-tech Enterprise in 2019, and passed ISO9001, ISO13485 quality management system and GMP certification.
 

PURPOSE

 
Develop superb Medical Device for people's health and benefits Innovation for systematic clinical solutions , and a world-wide intervention leader.

STRONG STRENGTH TO PRODUCE
HIGH-QUALITY PRODUCTS

The core R&D team was co-founded by senior technical personnel studying in the United States for decades and a domestic R&D and operation team...
30+
R & D team
30+
Patent
30+
Research Team
10+
Technical Adviser

DIGITAL SHOWROOM

If you want to learn more about our manufacturing capabilities, you can click on the avatar in the scene, or accept my invitation!

CERTIFICATE

CONTACT US TO GET A QUICK QUOTE

You can use our quick contact form to ask questions about our services. We are happy to answer your questions.

Contact us to get a quick quote

OEM/ODM SERVICE

Kossel Medtech has the strong technical team and complete production line to develop and produce stents. These stents can be used in cardiovascular and cerebrovascular, peripheral vascular and non vascular (esophagus, airway and biliary).
Laser Cutting
Heat Treatment
Electrochemical Polishing
Stents Griping
NEWSROOM
Kossel Medtech (Suzhou) Co., Ltd., established in 2013, has developed into a leading vascular intervention enterprise with comprehensive production and R&D capabilities. Manufacturing and R&D products include medical devices of the...
Exciting News | Seledora® Coronary Scoring Balloon Catheter Approved!

On March 14, 2025, Seledora® Coronary Scoring Balloon Catheter, developed by Mixin Medtech(Suzhou) Co., Ltd., a subsidiary of Kossel Medtech (Suzhou) Co., Ltd., received approval from the National Medical Products Administration (NMPA) for market launch (Registration No. 20253030586). Kossel's indep

Good news! Octoparms® Ⅱ Vena Cava Filter Obtained NMPA Certificate!

On March 14, 2025, the Octoparms® II vena cava filter independently developed by Kossel Medtech (Suzhou) Co., Ltd. was approved by the National Drug Administration (NMPA). (registration number is 20253130576). In addition, the Seledora® coronary scoring balloon catheter developed by the subsidiary M

An Analysis of The "Long-lasting Efficacy" of The MiStent Stent

The MiStent coronary drug-eluting stent, an important overseas transformation project of Corecell Medical, has officially entered the Chinese market with two major advantages of "rapid healing and long-lasting efficacy", providing a new clinical option for PCI surgeries.This issue will introduce the

GET IN TOUCH

 2F-3F, Building 6, No.8 Jinfeng Road, Suzhou New District, 215163, P.R. China. 
+86-512-8717-4080
+86-512-8717-4081

CONTACT US

Feedback

Copyright © 2022 Kossel Medtech (Suzhou) Co., Ltd. Support by  Leadong   Sitemap